HGH, GRENAA A/S: Financial statements 2012
CVR: 33120753
Source: annual report 2012, Danish Business Authority
01/10/2011 – 30/09/2012
HGH, GRENAA A/S (CVR 33120753) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -8,750 and a net result of DKK -361,509. Equity in the 2012 report amounted to DKK 3,188,807. The solvency ratio was 87.3%.
- Gross Profit
- DKK -8,750
- Profit/Loss
- DKK -361,509
- Equity
- DKK 3,188,807
- Total Assets
- DKK 3,654,007
Official annual report
Keep an eye on HGH, GRENAA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 28, 2012, EY Godkendt Revisionspartnerselskab has been appointed auditor of HGH, GRENAA A/S.
As of August 28, 2012, REVISIONSFIRMAET KVIST OG JENSEN A/S has stepped down as auditor of HGH, GRENAA A/S.
About HGH, GRENAA A/S
HGH, GRENAA A/S is a Danish company of the type Aktieselskab based in Grenaa, founded in 2010. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Louise Rørbæk Jensen. The board consists of Mette Rørbæk Jensen (chair), Jess Stegger and Louise Rørbæk Jensen. The company is owned by Boet efter Ulla Merethe Rørbæk Jensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,125 and a net result of DKK -1,506,927 compared with DKK 84,836 the year before. Equity in the 2025 report amounted to DKK -789,690.